Genes (Apr 2022)

<i>SCN1A</i> Variants as the Underlying Cause of Genetic Epilepsy with Febrile Seizures Plus in Two Multi-Generational Colombian Families

  • Diana M. Cornejo-Sanchez,
  • Anushree Acharya,
  • Thashi Bharadwaj,
  • Lizeth Marin-Gomez,
  • Pilar Pereira-Gomez,
  • Liz M. Nouel-Saied,
  • University of Washington Center for Mendelian Genomics,
  • Deborah A. Nickerson,
  • Michael J. Bamshad,
  • Heather C. Mefford,
  • Isabelle Schrauwen,
  • Jaime Carrizosa-Moog,
  • William Cornejo-Ochoa,
  • Nicolas Pineda-Trujillo,
  • Suzanne M. Leal

DOI
https://doi.org/10.3390/genes13050754
Journal volume & issue
Vol. 13, no. 5
p. 754

Abstract

Read online

Genetic epilepsy with febrile seizures plus (GEFS+) is an autosomal dominant disorder with febrile or afebrile seizures that exhibits phenotypic variability. Only a few variants in SCN1A have been previously characterized for GEFS+, in Latin American populations where studies on the genetic and phenotypic spectrum of GEFS+ are scarce. We evaluated members in two multi-generational Colombian Paisa families whose affected members present with classic GEFS+. Exome and Sanger sequencing were used to detect the causal variants in these families. In each of these families, we identified variants in SCN1A causing GEFS+ with incomplete penetrance. In Family 047, we identified a heterozygous variant (c.3530C > G; p.(Pro1177Arg)) that segregates with GEFS+ in 15 affected individuals. In Family 167, we identified a previously unreported variant (c.725A > G; p.(Gln242Arg)) that segregates with the disease in a family with four affected members. Both variants are located in a cytoplasmic loop region in SCN1A and based on our findings the variants are classified as pathogenic and likely pathogenic, respectively. Our results expand the genotypic and phenotypic spectrum associated with SCN1A variants and will aid in improving molecular diagnostics and counseling in Latin American and other populations.

Keywords